Multimodal AI Predicts Breast Cancer Recurrence from Pathology Slides, Published in Nature Communications
kjgeras · x · 2026-07-06
A research team published a paper in Nature Communications introducing a multimodal AI testing system based on routine breast cancer hematoxylin-eosin (H&E) stained pathology slides. It can predict postoperative recurrence risk across different invasive breast cancer subtypes.
By integrating computational pathology with multimodal AI fusion technology, the system aims to provide a low-cost, convenient prognostic assessment tool for clinical use, reducing the reliance on expensive additional molecular testing. The significance lies in leveraging routine pathology images already available in daily clinical practice to achieve more precise risk stratification.
More from Research
- Hierarchical continuous flow language models make pathwise RL more robust to critic exploitation — vxnuaj · 2026-10-27
- rauchg reproduces OpenAI's covert CPU-channel finding: chat across Firecracker microVMs with no network — ccerrato147 · 2026-10-27
- Microsoft Research: ForkPilot cuts long-horizon agent compute by up to 59% — EliasEskin · 2026-10-27
- Microsoft's TeleTune evolves agent skills from offline user telemetry — EliasEskin · 2026-10-27
- FlexGlue: sparse-to-dense matching that beats dense accuracy at a fraction of the cost — zhenjun_zhao · 2026-10-27
- PixGR: pixel-space generative decoding for fast feed-forward 3D Gaussian reconstruction — zhenjun_zhao · 2026-10-27